Financial Partners Group (Kansas)’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $275K | Buy |
1,484
+10
| +0.7% | +$1.86K | 0.04% | 168 |
|
2025
Q1 | $309K | Sell |
1,474
-678
| -32% | -$142K | 0.05% | 143 |
|
2024
Q4 | $382K | Sell |
2,152
-37
| -2% | -$6.57K | 0.06% | 122 |
|
2024
Q3 | $432K | Buy |
2,189
+8
| +0.4% | +$1.58K | 0.06% | 117 |
|
2024
Q2 | $374K | Sell |
2,181
-499
| -19% | -$85.6K | 0.06% | 122 |
|
2024
Q1 | $488K | Buy |
2,680
+1,019
| +61% | +$186K | 0.08% | 108 |
|
2023
Q4 | $257K | Sell |
1,661
-52
| -3% | -$8.06K | 0.05% | 138 |
|
2023
Q3 | $236K | Buy |
1,713
+278
| +19% | +$38.4K | 0.05% | 137 |
|
2023
Q2 | $212K | Sell |
1,435
-1,116
| -44% | -$165K | 0.04% | 146 |
|
2023
Q1 | $407K | Buy |
2,551
+210
| +9% | +$33.5K | 0.09% | 98 |
|
2022
Q4 | $360K | Buy |
+2,341
| New | +$360K | 0.08% | 110 |
|
2022
Q3 | – | Sell |
-1,356
| Closed | -$208K | – | 144 |
|
2022
Q2 | $208K | Buy |
1,356
+6
| +0.4% | +$920 | 0.05% | 138 |
|
2022
Q1 | $219K | Buy |
+1,350
| New | +$219K | 0.05% | 151 |
|